Invest now

Epigral Profit & Loss Annual

BSE: 543332 | NSE: EPIGRAL | ISIN: INE071N01016 | Sector: Chemical Manufacturing
1,096.30 -21.10 (-1.89%)Updated : 14 Aug 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 2,127.351,971.921,570.851,605.88
Other Net 0.89-6.22-13.64-17.75
Diluted Weighted Average Shares 4.314.224.164.16
Gain( Loss)on Saleof Assets 6.555.04-0.050.00
Depreciation/ Amortization 168.29132.56123.56108.95
Operating Income 399.83578.21358.34582.52
Net Income 331.97357.69195.87353.29
Income Availableto Com Excl Extra Ord 331.97357.69195.87353.29
Other Operating Expenses Total 115.67108.5184.6677.32
Net Income Before Taxes 340.76541.09290.75522.46
Net Income After Taxes 331.97357.69195.87353.29
Income Availableto Com Incl Extra Ord 331.97357.69195.87353.29
Costof Revenue Total 1,653.111,539.381,220.941,290.43
Gross Profit 874.071,010.75708.25897.97
Interest Inc( Exp) Net- Non- Op Total -66.51-35.94-53.89-42.31
Diluted Net Income 331.97357.69195.87353.29
DPS- Common Stock Primary Issue 5.006.005.005.00
Provisionfor Income Taxes 8.79183.4094.88169.17
period Type ----
Net Income Before Extra Items 331.97357.69195.87353.29
Total Revenue 2,527.182,550.131,929.192,188.40
period Length 12.0012.0012.0012.00
Revenue 2,527.182,550.131,929.192,188.40
Selling/ General/ Admin Expenses Total 189.42190.92141.69129.18
Diluted Normalized EPS 75.4783.8947.1585.03
Research Development 0.860.55--
Diluted EPS Excluding Extra Ord Items 76.9584.6847.1485.03
*All figures in crores except per share values
Recommended For You
Trending Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)